德展健康
(000813)
| 流通市值：67.72亿 | | | 总市值：67.74亿 |
| 流通股本：20.97亿 | | | 总股本：20.97亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 142,633,396.76 | 88,623,591.58 | 396,809,685.19 | 277,500,292.6 |
| 营业总成本 | 195,413,055.78 | 120,004,752.18 | 557,810,924.68 | 334,353,078.61 |
| 其他经营收益 | | | | |
| 营业利润 | -67,209,178.91 | -41,146,462.68 | -419,334,479.88 | -76,289,525.33 |
| 利润总额 | -67,602,267.09 | -41,062,740.36 | -420,422,134.55 | -76,563,467.44 |
| 净利润 | -75,307,710.7 | -43,167,923.15 | -421,925,827.96 | -88,537,198.97 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | -60,038,939.79 | - |
| 综合收益总额 | -75,307,710.7 | -43,167,923.15 | -481,964,767.75 | -88,537,198.97 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,121,211,916.97 | 2,171,848,443.41 | 2,568,209,713.74 | 3,186,407,470.45 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,648,329,635.22 | 2,629,250,718.35 | 2,303,799,890.56 | 2,046,922,577.07 |
| 资产总计 | 4,769,541,552.19 | 4,801,099,161.76 | 4,872,009,604.3 | 5,233,330,047.52 |
| 流动负债: | | | | |
| 流动负债合计 | 133,448,970.4 | 130,103,193.26 | 155,799,089.35 | 110,684,607.15 |
| 非流动负债: | | | | |
| 非流动负债合计 | 138,591,021.85 | 141,542,060.09 | 143,700,597.62 | 160,404,041.83 |
| 负债合计 | 272,039,992.25 | 271,645,253.35 | 299,499,686.97 | 271,088,648.98 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,577,726,401.4 | 4,601,314,589.03 | 4,635,625,619.48 | 4,976,363,182.26 |
| 股东权益合计 | 4,497,501,559.94 | 4,529,453,908.41 | 4,572,509,917.33 | 4,962,241,398.54 |
| 负债和股东权益合计 | 4,769,541,552.19 | 4,801,099,161.76 | 4,872,009,604.3 | 5,233,330,047.52 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 170,096,685.38 | 119,846,853.29 | 476,284,499.92 | 380,654,507.16 |
| 经营活动现金流出小计 | 222,390,579.16 | 103,760,383.8 | 471,562,016.8 | 354,243,357.35 |
| 经营活动产生的现金流量净额 | -52,293,893.78 | 16,086,469.49 | 4,722,483.12 | 26,411,149.81 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 6,393,175 | 3,303,665 | 10,613,088.85 | 5,368,999.88 |
| 投资活动现金流出小计 | 415,439,130.64 | 380,838,187.75 | 695,988,546.05 | 196,921,325.46 |
| 投资活动产生的现金流量净额 | -409,045,955.64 | -377,534,522.75 | -685,375,457.2 | -191,552,325.58 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 0 | 0 | 118,800,000 | 118,800,000 |
| 筹资活动现金流出小计 | 4,727,511.34 | 2,311,295.46 | 139,596,527.89 | 136,006,267.42 |
| 筹资活动产生的现金流量净额 | -4,727,511.34 | -2,311,295.46 | -20,796,527.89 | -17,206,267.42 |
| 汇率变动对现金及现金等价物的影响 | 0 | 0 | 70.93 | 70.96 |
| 现金及现金等价物净增加额 | -466,067,360.76 | -363,759,348.72 | -701,449,431.04 | -182,347,372.23 |
| 期末现金及现金等价物余额 | 1,290,061,750.33 | 1,392,369,762.37 | 1,756,129,111.09 | 2,275,231,169.9 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -466,067,360.76 | - | -701,449,431.04 | - |